NovaBay Pharmaceuticals, Inc. Trade and Non-Trade Receivables Growth

Trade and Non-Trade Receivables Growth of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Trade and Non-Trade Receivables Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Trade and Non-Trade Receivables Growth for the quarter ending June 30, 2022 was -0.11 (a -108.95% decrease compared to previous quarter)
  • Year-over-year quarterly Trade and Non-Trade Receivables Growth decreased by -55.88%
  • Annual Trade and Non-Trade Receivables Growth for 2021 was 0.51 (a 1254.93% increase from previous year)
  • Annual Trade and Non-Trade Receivables Growth for 2020 was 0.04 (a -105.4% decrease from previous year)
  • Annual Trade and Non-Trade Receivables Growth for 2019 was -0.69 (a 1061.87% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Trade and Non-Trade Receivables Growth of NovaBay Pharmaceuticals, Inc.

Most recent Trade and Non-Trade Receivables Growthof NBY including historical data for past 10 years.

Interactive Chart of Trade and Non-Trade Receivables Growth of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Trade and Non-Trade Receivables Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.11 1.22
2021 0.51 -0.25 -0.11 0.09 0.51
2020 0.04 -0.26 -0.09 -0.61 0.04
2019 -0.69 -0.42 -0.24 0.09 -0.69
2018 -0.07 0.17 -0.44 -0.05 -0.06
2017 0.71 0.07 1.42 0.56 0.75
2016 2.96 2.83 2.83 4.29 2.96
2015 0.96 0.49 -0.12 0.09 0.96
2014 -0.65 0.34 2.93 -0.72 -0.65
2013 -0.17 1.16 11.44 -0.09 -0.17
2012 313.33 -0.93 -1.0 1.02 313.33
2011 -0.9 -0.99

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology